DongKi Lee - OliX PharmaceuticalsI CEO Director

226950 Stock   48,250  5,650  10.48%   

Insider

DongKi Lee is CEO Director of OliX PharmaceuticalsInc
Age 51
Phone82 3 1779 8400
Webhttp://www.olixpharma.com

OliX PharmaceuticalsI Management Efficiency

The company has return on total asset (ROA) of (0.164) % which means that it has lost $0.164 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (76.6277) %, meaning that it generated substantial loss on money invested by shareholders. OliX PharmaceuticalsI's management efficiency ratios could be used to measure how well OliX PharmaceuticalsI manages its routine affairs as well as how well it operates its assets and liabilities.
OliX PharmaceuticalsInc has accumulated 20.38 B in total debt. Debt can assist OliX PharmaceuticalsI until it has trouble settling it off, either with new capital or with free cash flow. So, OliX PharmaceuticalsI's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like OliX PharmaceuticalsInc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for OliX to invest in growth at high rates of return. When we think about OliX PharmaceuticalsI's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

SungHee SonOscotec
N/A
Young ChoLegoChem Biosciences
N/A
Ho SongLegoChem Biosciences
N/A
HeeSeok JooMedy Tox
57
SeNyun KimOscotec
N/A
JaeSang LeeOscotec
N/A
YongIn KimMedy Tox
61
SeungChul LeeOscotec
60
Hirose DakashiOscotec
N/A
Hyang LeeLegoChem Biosciences
N/A
KiHyuk YangMedy Tox
54
Dae LeeLegoChem Biosciences
N/A
Jaecheon LeeABL Bio
N/A
JuWon KimOscotec
N/A
Sejin ParkLegoChem Biosciences
61
Jung KimABL Bio
N/A
Sang LeeABL Bio
N/A
WooSun LeeMedy Tox
46
Jong WonABL Bio
N/A
SoJin AhnOscotec
N/A
You WeonKyooABL Bio
N/A
OliX PharmaceuticalsInc (226950) is traded on KOSDAQ in Korea and employs 67 people.

Management Performance

OliX PharmaceuticalsInc Management Team

Elected by the shareholders, the OliX PharmaceuticalsI's board of directors comprises two types of representatives: OliX PharmaceuticalsI inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OliX. The board's role is to monitor OliX PharmaceuticalsI's management team and ensure that shareholders' interests are well served. OliX PharmaceuticalsI's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OliX PharmaceuticalsI's outside directors are responsible for providing unbiased perspectives on the board's policies.
SunWoo Hong, VP Director
Shin Park, Sr Devel
DongKi Lee, CEO Director

OliX Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is OliX PharmaceuticalsI a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Other Information on Investing in OliX Stock

OliX PharmaceuticalsI financial ratios help investors to determine whether OliX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in OliX with respect to the benefits of owning OliX PharmaceuticalsI security.